Lijian Liu

Lijian Liu


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2025 in World Journal of Gastrointestinal Surgery
Verified
Journal Article
Open access
JLJian-Feng Li
Jian-Feng Li
MXMin-Jian Xie
Min-Jian Xie
JWJin-Xiu Wei
Jin-Xiu Wei
CYCheng-Ning Yang
Cheng-Ning Yang
GCGuang-Wen Chen
Guang-Wen Chen
SXSheng Xie
Sheng Xie
BACKGROUND Pancreaticobiliary maljunction (PBM) is a rare congenital abnormality in pancreaticobiliary duct development. PBM is commonly found in children, and it often leads to acute pancreatitis and other diseases as a result of pancreaticobiliary reflux. Roux-en-Y choledochojejunostomy is a common surgical method for the treatment of PBM, but there are several associated complications that may occur after this operation. CASE SUMMARY The patient, a 12-year-old female, was hospitalized nearly 20 times in 2021 for recurrent acute pancreatitis. In 2022, she was diagnosed with PBM and underwent laparoscopic common bile duct resection and Roux-en-Y choledochojejunostomy in a tertiary hospital. In the first year after surgery, the patient had more than 10 recurrent acute pancreatitis episodes. After undergoing abdominal computed tomography and other examinations, she was diagnosed with “residual bile duct stones and recurrent acute pancreatitis”. On January 30, 2024, the patient was admitted to our hospital due to recurrent upper abdominal pain and was cured through endoscopic retrograde cholangiopancreatography. CONCLUSION This article reports a case of a child with distal residual common bile duct stones and recurrent acute pancreatitis after Roux-en-Y choledochojejunostomy for PBM. The patient was cured through endoscopic retrograde cholangiopancreatography.

6 September 2024 in Medicine
Verified
Journal Article
Open access
LLLiqun Li
Liqun Li
JYJing Mm Yan
Jing Mm Yan
QLQian Bs Liu
Qian Bs Liu
LGLaian Ge
Laian Ge
YPYifeng Mm Pan
Yifeng Mm Pan
XSXie Sheng
Xie Sheng
Previous studies have confirmed the affiliation between specific inflammatory cytokines and Hepatic fibrosis (HF); however, contradictions remain in the causality. The study implemented a bidirectional two-sample Mendelian randomization (MR) analysis with published statistics derived from Genome-wide Association Studies (GWAS) to investigate casualties between inflammatory cytokines and HF. Additionally, MR analysis was also introduced to consider if 1400 blood metabolites act as the key mediators in this process. Single nucleotide polymorphisms (SNPs) with strong correlations to inflammatory factors were selected for multiple MR analyses in this study. The inverse variance weighted method (IVW) was chosen as the principal analysis, and the others as the supportive. Besides, sensitivity tests were involved to identify potential heterogeneity and pleiotropic level. IVW methods revealed that a relatively high level of prediction-based monocyte chemoattractant protein-4 (MCP-4) (95% CI: 1.014–3.336, P = .045), along with neurturin (NRTN) (95% CI: 1.204–4.004, P = .010), may increase the risk of HF; while programmed cell death 1 ligand 1 (PD-L1) (95% CI: 0.223–0.928, P = .030), showed a protective effect on HF. No significant statistical differences were detected on any other inflammatory cytokines, nor did the impact of HF genetic predisposition on the 91 circulating inflammatory cytokines-related characteristics.

30 May 2025 in Medicine
Verified
Journal Article
Open access
LLLiqun Li
Liqun Li
LLLijian Liu
Lijian Liu
JXJieru Mm Xie
Jieru Mm Xie
JPJin Chan Peng
Jin Chan Peng
GCGuangwen Mm Chen
Guangwen Mm Chen
XSXie Sheng
Xie Sheng
The associations between specific inflammatory cytokines and gastroesophageal reflux disease (GERD) have been confirmed, while their causal relationships remain unclear. We conducted a bidirectional 2-sample Mendelian randomization analysis (MRA) to reveal the causal correlations between 91 inflammatory factors and GERD, thereby conducting a 2-step MRA analysis to reveal the mediating function of 1400 metabolites therein. Data related to 91 inflammatory cytokines were derived from Genome-Wide Association Studies (GWAS) data with 14,824 samples. GWAS data about GERD were obtained from a large genome research project in Finland, including 28,859 GERD cases and 3,50,064 controls. GWAS data about 1400 circulating metabolites were derived from a cohort of 8299 individuals. The inverse variance weighted approach was introduced to obtain the primary MRA results, complemented by 4 additional methods for supportive analyses. Additionally, the study conducted sensitivity analyses with different methods to evaluate heterogeneity and horizontal pleiotropy. Our findings indicated that higher predicted C-X-C motif chemokine 1 [OR = 1.052, 95% CI: 1.004 − 1.103, P = .035], interleukin-1-alpha [OR = 1.083, 95% CI: 1.018 − 1.152, P = .012], and interleukin-4 [IL-4, OR = 1.081, 95% CI: 1.018 − 1.147, P = .011] increased the risk of GERD; whereas tumor necrosis factor ligand superfamily member 12 [OR = 0.958, 95% CI: 0.9174–0.9999, P = .0493] decreased the risk of GERD. No significant statistical differences were found for other inflammatory cytokines. Genetic susceptibility to GERD had no impact on any traits related to circulating inflammatory cytokines. Four metabolites associated with elevated IL-4 levels were identified, including (1-enyl-oleoyl)-GPE (P-18:1), 4-methyl guaiacol sulfate, X-12730, and X-17685, but their mediating effects were not statistically significant (P > .05). This study convincingly proved the causal impact of inflammatory factors on GERD. It confirms that C-X-C motif chemokine 1, interleukin-1-alpha, and IL-4 increase the risk of GERD, while tumor necrosis factor ligand superfamily member 12 reduces it. Additionally, several circulating metabolites are associated with elevated IL-4 levels. However, the evidence for their role as potential mediators in the pathway between IL-4 and GERD risk remains insufficient. The findings of this study propel further comprehension of the pathogenesis of GERD and also point out the therapeutic potential for interventions targeting inflammatory cytokine-targeted inventions.

13 February 2026 in Medicine
Verified
Journal Article
Open access
LLLiqun Li
Liqun Li
LLLijian Liu
Lijian Liu
JYJing Yan
Jing Yan
JTJinjing Tan
Jinjing Tan
XSXie Sheng
Xie Sheng
The causal relationships between antibody-induced immune responses and the occurrence and mortality of sepsis remain controversial. The 2-sample Mendelian randomization (MR) approach was utilized to reveal the causal associations, along with the potential mediation effects of inflammatory cytokines. The causal associations were analyzed by a 2-sample bidirectional MR analysis, primarily using the inverse variance weighted method. MR-Egger regression, weighted mode, weighted median, and simple mode were conducted as supplementary analyses. Additionally, we performed a 2-step MR to investigate the potential mediation effects of 91 inflammatory cytokines. Cochran Q test was conducted to assess statistical heterogeneity. Potential horizontal pleiotropy was identified with MR-Egger regression intercept test and MR-pleiotropy residual sum and outlier global test. Leave-one-out sensitivity analysis was employed to evaluate the influence of an individual single nucleotide polymorphism on the estimates. The outcomes revealed positive associations between genetically predicted Helicobacter pylori urea antibody levels (odds ratios [ORs] = 1.070, 95% confidence interval [CI]: 1.009–1.134, P = .024), anti-herpes simplex virus type 1 immunoglobulin G seropositivity [OR = 1.071, 95% CI: 1.012–1.134, P = .018], and the risk of sepsis; cytomegalovirus phosphoprotein 52 antibody levels showed significant negative correlation with 28-day mortality in sepsis [OR = 0.830, 95% CI: 0.690–0.999, P = .048]. Surprisingly, the mediation analysis suggested that the 91 inflammatory cytokines did not mediate these associations. H pylori urea antibody and anti-herpes simplex virus type 1 immunoglobulin G seropositivity are pathogenic factors for sepsis, while cytomegalovirus phosphoprotein 52 antibody levels may protect against 28-day mortality in sepsis. Inflammatory cytokines may not mediate these relationships. These findings could contribute to the precise management of sepsis.

11 July 2025 in Medicine
Verified
Journal Article
Open access
LLLiqun Mm Li
Liqun Mm Li
LLLijian Liu
Lijian Liu
JTJinJing Tan
JinJing Tan
HPHongxia Bs Pan
Hongxia Bs Pan
CYChengning Mm Yang
Chengning Mm Yang
XSXie Sheng
Xie Sheng
Studies have proven an association between the specific antibody-mediated immune response and gastroesophageal reflux disease (GERD); however, the exact causal associations remain unclear. Our research aims to evaluate the causal relationships between the genetic susceptibility to 46 antibody-mediated immune responses and GERD, with the bidirectional two-sample Mendelian randomization (TSMR) and to explore the mediating effects of 91 circulating inflammatory cytokines by a two-step MR analysis. Multiple MR analysis methods, including inverse variance weighted, MR-Egger, weighted mode, weighted median, simple mode, and MR pleiotropy residual sum and outlier, were employed for the bidirectional TSMR analysis. Besides, sensitivity analyses, such as Cochran Q statistics, MR-Egger intercept, MR pleiotropy residual sum and outlier global test, and the leave-one-out method were implemented to identify potential heterogeneity and pleiotropy. In the forward MR analysis, the inverse variance weighted method demonstrated that anti-cytomegalovirus (anti-CMV) IgG seropositivity (OR = 1.031, 95% CI: 1.000–1.062, P = .048), levels of human herpes virus (HHV) 7 U14 antibody (OR = 1.097, 95% CI: 1.032–1.167, P = .003), and herpes simplex virus 1 (HSV-1) mgG-1 antibody (OR = 1.069, 95% CI: 1.020–1.119, P = .005), which have higher genetic prediction, are positively related to GERD risks. Reverse MR analysis revealed GERD increased the level of Epstein–Barr virus VCA p18 antibody (OR = 1.255, 95% CI: 1.028–1.533, P = .026), while decreased the anti-CMV IgG seropositivity (OR = 0.663, 95% CI: 0.444–0.991, P = .045) and HHV 7 U14 antibody level (OR = 0.777, 95% CI: 0.630–0.958, P = .018) as well. Besides, other antibodies, including anti-Helicobacter pylori (H pylori) IgG, H pylori CagA, and H pylori VacA demonstrated no correlations (neither positive nor negative) with GERD risks. Surprisingly, TSMR showed that 91 cytokines seemed not to mediate HSV-1 mgG-1 to enhance GERD risks. The research provided convincing evidence for establishing a causal relationship between antibody-mediated immune responses and GERD, proving that genetic-prediction-based HSV-1 mgG-1 could increase GERD risk and that inflammatory factors may not be involved in mediating this association. Besides, GERD was found to reduce Epstein–Barr virus VCA p18 antibody. Moreover, we revealed the bidirectional causal relationships between GERD and the antibodies, including anti-CMV IgG, HHV 7 U14. This research may contribute to a better understanding of the mechanism that triggers GERD, also emphasizing the clinical potential of therapeutic interventions targeting antibody-mediated immune responses.